Strides Pharma Science Profile
Key Indicators
- Authorised Capital ₹ 188.37 Cr
as on 05-07-2024
- Paid Up Capital ₹ 91.92 Cr
as on 05-07-2024
- Company Age 34 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2,368.48 Cr
as on 05-07-2024
- Satisfied Charges ₹ 9,800.46 Cr
as on 05-07-2024
- Revenue 14.80%
(FY 2024)
- Profit 1298.78%
(FY 2024)
- Ebitda 159.22%
(FY 2024)
- Net Worth 3.07%
(FY 2024)
- Total Assets 3.88%
(FY 2024)
About Strides Pharma Science
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532531 and on the National Stock Exchange(NSE) under STAR.
The Corporate was formerly known as Strides Pharma Sciences Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 188.37 Cr and a paid-up capital of Rs 91.92 Cr.
The company currently has active open charges totaling ₹2,368.48 Cr. The company has closed loans amounting to ₹9,800.46 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Strides Pharma Science Limited India are Vikesh Kumar as Cfo, Manjula Ramamurthy as Company Secretary, and Badree Komandur as Ceo. Kausalya Santhanam, Subir Chakraborty, Homi Khusrokhan, and Six other members serve as directors at the Company.
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Strides Pharma Science Limited offer?
Strides Pharma Science Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Malaria Medicine.
Who are the key members and board of directors at Strides Pharma Science?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vikesh Kumar | CFO | 29-Jun-2024 | Current |
Badree Komandur  | Managing Director | 18-May-2017 | Current |
| Manjula Ramamurthy | Company Secretary | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subir Chakraborty | Additional Director | 29-Jun-2024 | Current |
| Srinivasan Sridhar | Director | 27-Jul-2012 | Current |
| Kausalya Santhanam | Director | 11-Dec-2019 | Current |
| Ameet Hariani | Director | 04-Mar-2024 | Current |
| Homi Khusrokhan | Director | 18-May-2017 | Current |
| Arun Pillai | Director | 24-May-2004 | Current |
Financial Performance and Corporate Structure Insights of Strides Pharma Science.
Strides Pharma Science Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 14.8% increase. The company also saw a substantial improvement in profitability, with a 1298.78% increase in profit. The company's net worth moved up by a moderate rise of 3.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Strides Pharma Science?
In 2023, Strides Pharma Science had a promoter holding of 28.28% and a public holding of 71.73%. The company had 3 Subsidiaries and 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Bengal Chamber Of Commerce And IndustryActive 131 years 6 monthsSubir Chakraborty is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Dec 2023 | ₹139.62 Cr | Open |
Hdfc Bank Limited Creation Date: 20 Oct 2023 | ₹6.44 M | Open |
Others Creation Date: 19 Sep 2023 | ₹150.00 Cr | Open |
How Many Employees Work at Strides Pharma Science?
Strides Pharma Science has a workforce of 2152 employees as of Nov 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strides Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strides Pharma Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
